BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 28927462)

  • 1. Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation.
    Huang J; Zhou S; Niu X; Hu B; Li Q; Zhang F; Zhang X; Cai X; Lou Y; Liu F; Xu C; Wang Y
    Stem Cell Res Ther; 2017 Sep; 8(1):196. PubMed ID: 28927462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients.
    Kenter AT; Rentmeester E; van Riet J; Boers R; Boers J; Ghazvini M; Xavier VJ; van Leenders GJLH; Verhagen PCMS; van Til ME; Eussen B; Losekoot M; de Klein A; Peters DJM; van IJcken WFJ; van de Werken HJG; Zietse R; Hoorn EJ; Jansen G; Gribnau JH
    Stem Cells Transl Med; 2020 Apr; 9(4):478-490. PubMed ID: 32163234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.
    Freedman BS; Lam AQ; Sundsbak JL; Iatrino R; Su X; Koon SJ; Wu M; Daheron L; Harris PC; Zhou J; Bonventre JV
    J Am Soc Nephrol; 2013 Oct; 24(10):1571-86. PubMed ID: 24009235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation.
    Lee JJ; Ho MC; Huang CY; Wen CH; Cheng YC; Hsu YH; Hwang DY; Lu HE; Chen HC; Hsieh PCH
    Stem Cell Res; 2017 Dec; 25():83-87. PubMed ID: 29121521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cardiac manifestation of autosomal dominant polycystic kidney disease revealed by patient induced pluripotent stem cell-derived cardiomyocytes.
    Lee JJ; Cheng SJ; Huang CY; Chen CY; Feng L; Hwang DY; Kamp TJ; Chen HC; Hsieh PCH
    EBioMedicine; 2019 Feb; 40():675-684. PubMed ID: 30639418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
    Cai Y; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an induced pluripotent stem cell line, IBMS-iPSC-014-05, from a female autosomal dominant polycystic kidney disease patient carrying a common mutation of R803X in PKD2.
    Ho MC; Huang CY; Lee JJ; Hsu SH; Cheng YC; Hsu YH; Hwang DY; Lu HE; Chen HC; Hsieh PCH
    Stem Cell Res; 2017 Dec; 25():38-41. PubMed ID: 29055226
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Kuraoka S; Tanigawa S; Taguchi A; Hotta A; Nakazato H; Osafune K; Kobayashi A; Nishinakamura R
    J Am Soc Nephrol; 2020 Oct; 31(10):2355-2371. PubMed ID: 32747355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilia and polycystic kidney disease.
    Ma M
    Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of MMP1 as a novel risk factor for intracranial aneurysms in ADPKD using iPSC models.
    Ameku T; Taura D; Sone M; Numata T; Nakamura M; Shiota F; Toyoda T; Matsui S; Araoka T; Yasuno T; Mae S; Kobayashi H; Kondo N; Kitaoka F; Amano N; Arai S; Ichisaka T; Matsuura N; Inoue S; Yamamoto T; Takahashi K; Asaka I; Yamada Y; Ubara Y; Muso E; Fukatsu A; Watanabe A; Sato Y; Nakahata T; Mori Y; Koizumi A; Nakao K; Yamanaka S; Osafune K
    Sci Rep; 2016 Jul; 6():30013. PubMed ID: 27418197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel ADPKD model using kidney organoids derived from disease-specific human iPSCs.
    Shimizu T; Mae SI; Araoka T; Okita K; Hotta A; Yamagata K; Osafune K
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1186-1194. PubMed ID: 32819584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of PKD1 gene in a Chinese family with autosomal dominant polycystic kidney disease.
    Liu J; Li L; Liu Q
    Int J Clin Exp Pathol; 2015; 8(10):13289-92. PubMed ID: 26722532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
    Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
    Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
    Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
    Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
    Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
    J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive PKD1 and PKD2 Mutation Analysis in Prenatal Autosomal Dominant Polycystic Kidney Disease.
    Audrézet MP; Corbiere C; Lebbah S; Morinière V; Broux F; Louillet F; Fischbach M; Zaloszyc A; Cloarec S; Merieau E; Baudouin V; Deschênes G; Roussey G; Maestri S; Visconti C; Boyer O; Abel C; Lahoche A; Randrianaivo H; Bessenay L; Mekahli D; Ouertani I; Decramer S; Ryckenwaert A; Cornec-Le Gall E; Salomon R; Ferec C; Heidet L
    J Am Soc Nephrol; 2016 Mar; 27(3):722-9. PubMed ID: 26139440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction.
    He WB; Xiao WJ; Tan YQ; Zhao XM; Li W; Zhang QJ; Zhong CG; Li XR; Hu L; Lu GX; Lin G; Du J
    BMC Med Genet; 2018 Oct; 19(1):186. PubMed ID: 30333007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient with a p.Ser1457fs mutation in PKD1.
    Huang CY; Ho MC; Lee JJ; Hwang DY; Ko HW; Cheng YC; Hsu YH; Lu HE; Chen HC; Hsieh PCH
    Stem Cell Res; 2017 Oct; 24():139-143. PubMed ID: 29034881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy.
    Losekoot M; Ruivenkamp CA; Tholens AP; Grimbergen JE; Vijfhuizen L; Vermeer S; Dijkman HB; Cornelissen EA; Bongers EM; Peters DJ
    J Med Genet; 2012 Jan; 49(1):37-40. PubMed ID: 22114106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
    Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.